CLOV - February 7, 2021
CLOV was bought out from a Chamath SPAC, this ticker has been in the headlines recently for investigation by the SEC for upping prices for healthcare services. Look for Chamath tweets and news on the stock to produce movement. From a technical standpoint, if we see a breakout look for resistance around 14.30 and 18 before moving higher with a 6-week price target of 24. Support is around 11.30, invalidation occurs around 12.20. CLOV has earnings coming up on February 25th, 2021 pre-market.
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。